Back
Speaker illustration

Doctor Peizhi Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

Member of:

Peizhi Wang completed his medical degree at the Southern Medical University, China. Subsequently, he pursues his direct entry PhD at the Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. Since 2023, he has been a joint PhD student at the Center for Molecular Cardiology, University of Zurich, Switzerland. He mainly researches on risk score, cardiovascular diabetology, novel biomarkers etc.

Presentations Articles

L-shaped association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Access
Thumbnail

The impact of the high-density lipoprotein cholesterol levels on long-term poor prognosis in patients with acute coronary syndrome: observations from a multicenter Asian cohort study

Event: ESC Acute CardioVascular Care 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Biomarkers and risk stratification in Acute Coronary Syndromes

Access
Thumbnail

Effect of the stress hyperglycemia ratio on long-term outcome in older patients with coronary heart disease: a multicenter cohort study

Event: ESC Acute CardioVascular Care 2023

Topic: Secondary Prevention

Session: Novel topics in acute cardiac care

Access
Thumbnail

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort

Event: ESC Preventive Cardiology 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session: Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb